Graham Capital Management »

Iteos Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $156k 14k 10.95

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Iteos Therapeutics

RA Capital Management
Boxer Capital
Vanguard Group
BVF
Citadel Advisors
EcoR1 Capital
Millennium Management
Dimensional Fund Advisors
Goldman Sachs Group
Deerfield Management Company
683 Capital Management
Jacobs Levy Equity Management
Artal Group
Ikarian Capital
Citigroup

View all funds holding Iteos Therapeutics